316 related articles for article (PubMed ID: 6967461)
1. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. II. Macrophage and lymphocyte interaction.
Birdi TJ; Salgame PR; Mahadevan PR; Antia NH
Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):178-82. PubMed ID: 6967461
[TBL] [Abstract][Full Text] [Related]
2. In vitro studies on the effect of levamisole in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Feb; 13(2):93-6. PubMed ID: 6374154
[TBL] [Abstract][Full Text] [Related]
3. Role of macrophages in defective cell mediated immunity in lepromatous leprosy. I. Factor(s) from macrophages affecting protein synthesis and lymphocyte transformation.
Salgame PR; Birdi TJ; Mahadevan PR; Antia NH
Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):172-7. PubMed ID: 7190553
[TBL] [Abstract][Full Text] [Related]
4. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
[TBL] [Abstract][Full Text] [Related]
5. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
[TBL] [Abstract][Full Text] [Related]
6. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
7. Biochemical alteration in cells following phagocytosis of M. leprae--the consequence--a basic concept.
Mahadevan PR; Antia NH
Int J Lepr Other Mycobact Dis; 1980 Jun; 48(2):167-71. PubMed ID: 6995358
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of immunosuppression in leprosy--macrophage membrane alterations.
Salgame PR; Birdi TJ; Lad SJ; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Jul; 14(3):145-9. PubMed ID: 6384522
[TBL] [Abstract][Full Text] [Related]
9. Fate of Mycobacterium leprae in macrophages of patients with lepromatous or tuberculoid leprosy.
Godal T; Rees RJ
Int J Lepr Other Mycobact Dis; 1970; 38(4):439-42. PubMed ID: 4929374
[No Abstract] [Full Text] [Related]
10. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
11. Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.
Nath I; Van Rood JJ; Mehra NK; Vaidya MC
Clin Exp Immunol; 1980 Nov; 42(2):203-10. PubMed ID: 6451335
[TBL] [Abstract][Full Text] [Related]
12. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients.
Corbeau P; Desforges S; Bach MA
Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800
[No Abstract] [Full Text] [Related]
13. Lymphocyte transformation test in lepromatous leprosy patients and their healthy siblings.
Sengupta SR; Yemul VL; Dhole TN
Lepr India; 1983 Apr; 55(2):261-4. PubMed ID: 6579324
[TBL] [Abstract][Full Text] [Related]
14. [Sequential activation of cellular and humoral immunity in leprosy: considerations based on recent findings].
Rojas-Espinosa O; Jiménez-Zamudio L; Arce-Paredes P
Rev Latinoam Microbiol; 1994; 36(3):213-9. PubMed ID: 7709098
[TBL] [Abstract][Full Text] [Related]
15. Radiolabelled M. leprae resident in human macrophage cultures as an in vitro indicator of effective immunity in human leprosy.
Prasad HK; Singh R; Nath I
Clin Exp Immunol; 1982 Sep; 49(3):517-22. PubMed ID: 6756718
[TBL] [Abstract][Full Text] [Related]
16. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the membrane of macrophages from leprosy patients.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
Infect Immun; 1983 Jul; 41(1):121-7. PubMed ID: 6345387
[TBL] [Abstract][Full Text] [Related]
18. A component of Mycobacterium leprae as immunomodulating agent for immune deficient cells of leprosy patients.
Robinson P; Mahadevan PR
J Clin Lab Immunol; 1987 Dec; 24(4):171-6. PubMed ID: 3329228
[TBL] [Abstract][Full Text] [Related]
19. Studies on the defect in cell-mediated immunity in lepromatous leprosy using HLA-D-identical siblings. Absence of circulating suppressor cells and evidence that the defect is in the T-lymphocyte, rather than the monocyte, population.
Stoner GL; Mshana RN; Touw J; Belehu A
Scand J Immunol; 1982 Jan; 15(1):33-48. PubMed ID: 6176016
[TBL] [Abstract][Full Text] [Related]
20. Macrophage membrane alterations in leprosy as determined by change in sialic acid level.
Agarwal S; Vemuri N; Mahadevan PR
J Clin Lab Immunol; 1986 Mar; 19(3):119-22. PubMed ID: 3519974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
